Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Silo Pharma, Inc. Common Stock (SILO)

Apparel & Other Finishd Prods Of Fabrics & Similar Matl

https://www.silopharma.com

SILO Pharma Inc is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. The company is engaged in developing innovative solutions to address a variety of underserved conditions which includes Alzheimer's; Parkinson's; Multiple Sclerosis (MS); Rheumatoid Arthritis (RA); and Stress-Induced Psychiatric Disorders.

560 SYLVAN AVE, SUITE 3160
ENGLEWOOD CLIFFS, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/05/2012

Market Cap

6,749,112

Shares Outstanding

3,110,000

Weighted SO

3,108,797

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

PTIXW --.--%

RZLT --.--%

LUMO --.--%

ANEB --.--%

SBMFF --.--%

IVA --.--%

BCDA --.--%

URGN --.--%

INDP --.--%

Beta

1.4620

Last Div

0.0000

Range

0.841-4.5

Chg

0.1450

Avg Vol

5285711

Mkt Cap

6749112

Exch

NASDAQ

Country

US

Phone

718 400 9031

DCF Diff

0.8429

DCF

0.6025

Div Yield

0.0000

P/S

93.6051

EV Multiple

-0.6056

P/FV

0.7711

Div Yield %

0.0000

P/E

-1.3071

PEG

-0.0686

Payout

0.0000

Current Ratio

5.8424

Quick Ratio

5.8424

Cash Ratio

3.4064

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

897.8875

CCC

-897.8875

Gross Margin

-6.0519

Op Margin

-52.9723

Pretax Margin

-47.7821

Net Margin

-48.7474

Eff Tax Rate

0.0258

ROA

-0.4373

ROE

-0.5641

ROCE

-0.5688

NI/EBT

1.0202

EBT/EBIT

0.9020

EBIT/Rev

-52.9723

Debt Ratio

-0.1556

D/E

-0.2099

LT Debt/Cap

0.0000

Total Debt/Cap

-0.2657

Int Coverage

-2804.2636

CF/Debt

2.8397

Equity Multi

1.3492

Rec Turnover

0.0000

Pay Turnover

0.4065

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0090

OCF/Share

-1.1635

FCF/Share

-1.1635

Cash/Share

2.4924

OCF/Sales

-49.2611

FCF/OCF

1.0000

CF Coverage

2.8397

ST Coverage

2.8397

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.7711

P/B

0.7711

P/S

93.6051

P/E

-1.3071

P/FCF

-1.9002

P/OCF

-1.2935

P/CF

-1.2935

PEG

-0.0686

P/S

93.6051

EV Multiple

-0.6056

P/FV

0.7711

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 04, 08:55 Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD GlobeNewswire Inc. Dec 28, 08:25 Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia PennyStocks Dec 18, 14:46 3 Essential Strategies for Penny Stocks Trading in 2024 PennyStocks Dec 18, 14:46 3 Essential Strategies for Penny Stocks Trading in 2024

Revenue Product Segmentation